Wall Street closes higher, Nasdaq sets record as potential vaccines show promise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Morgan Stanley Reiterates Equalweight Rating on Pfizer (PFE) Following COVID Vaccine Update
July 21, 2020 8:42 AM EDTMorgan Stanley analyst David Risinger reiterated an Equalweight rating and $36.00 price target on Pfizer (NYSE: PFE) following the company's COVID vaccine update. Results appear encouraging vs. MRNA and AZN, but x-trial comps are confounded.
Risinger await results from BNT162b2(full spike)... More
Amazon (AMZN) Hovers Near Session High, Up 7%
July 20, 2020 2:55 PM EDTAmazon (NASDAQ: AMZN) Hovers Near Session High, Up 7%
... MoreTesla (TSLA) adds to gains, shares now up 8.2%
July 20, 2020 1:43 PM EDTTesla (NASDAQ: TSLA) adds to gains, shares now up 8.2%
... MoreAmazon (AMZN) Continues to Outperform Major Indexes, Up 4.75% to $3,100
July 20, 2020 11:30 AM EDTAmazon (NASDAQ: AMZN) Continues to Outperform Major Indexes, Up 4.75% to $3,100
Mizuho 'Encouraged' by Pfizer (PFE) COVID-19 Vaccine Data
July 20, 2020 10:57 AM EDTMizuho Securities analyst Vamil Divan reiterated a Buy rating and $38.00 price target on Pfizer (NYSE: PFE), citing continued positive progress on its COVID vaccine.
The analyst commented, "We are encouraged by new data from Pfizer and partner BioNTech on the progress they are... More
Amazon.com (AMZN) PT Raised to $3,350 at MKM Partners
July 20, 2020 8:15 AM EDTMKM Partners analyst Rohit Kulkami raised the price target on Amazon.com (NASDAQ: AMZN) to $3,350.00 (from $2,525.00) while maintaining a Buy rating.
The analyst comments "We are increasing our 2020 and 2021 Revenue & EPS estimates (again). Our 2021 Revenue estimates are now 8% above pre-Covid levels, but... More



